Gilead Sciences Inc. (NASDAQ:GILD) dropped over 2.4% in last trading session following released that its Q3 profit of $2.73B that was lower than anticipation. On a per-share basis, the Foster City, California-based firm declared that it had profit of $1.67. Earnings, adjusted for one-time gains and costs, came to $1.84 a share. Shares of Gilead Sciences Inc. (NASDAQ:GILD) opened at $110.00 with 1511.67 million outstanding shares and hit to its highest price of $113.425 during the day and finally closed at $110.72 by scoring -2.41%.Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) declared that it will hold a conference call and webcast on Thursday, November 6, 2014 at 2 p.m. Pacific Time (5 p.m. Eastern Time) to provide a corporate update and report financial results for the third quarter ended Sept 30, 2014. On the other consideration, Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) begun last trade with a price of $18.20 and throughout the trading session climbed at $18.20. The day-trade ended with a loss of -7.97% to close at $16.87.Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai (ESALY) recently announced top-line results of a pilot study to assess the safety of lorcaserin HCl, a serotonin 2C receptor agonist, at what time coadministered with phentermine HCl. The results of the investigational study demonstrate with the intention of the short-term combination of lorcaserin plus phentermine does not appear to be associated with an exacerbation in the proportion of pre-specified adverse events compared to therapy with lorcaserin alone. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock hit highest price at $4.52, beginning with a price of $4.43 to the closed at 4.26 by a decrease of -2.07% with a day range of $4.22-$4.52.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
